Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
5.45
+0.21 (4.01%)
At close: Aug 14, 2026, 4:00 PM EDT
5.44
-0.01 (-0.24%)
After-hours: Aug 14, 2026, 7:37 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $2.7 billion as of August 14, 2026. Its market cap has decreased by -59.31% in one year.
Market Cap
2.70B
Enterprise Value
2.70B
1-Year Change
-59.31%
Ranking
Category
Stock Price
$5.45
ChartMarket Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $2.70B, an increase of 2,148.40%. That is a compound annual growth rate of 84.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.70B | -74.00% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.79B |
| Prestige Consumer Healthcare | 2.46B |
| BioCryst Pharmaceuticals | 2.46B |
| Bausch Health Companies | 2.42B |
| Amylyx Pharmaceuticals | 2.40B |
| HUTCHMED (China) | 2.18B |
| Trulieve Cannabis | 1.84B |
| Perrigo Company | 1.78B |